Roivant Sciences ROIV
NASDAQ ROIV
$35.72 +0.22 (+0.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

Roivant Sciences (ROIV) Property, Plant & Equipment (Net) (2021 - 2026)

Updated

Roivant Sciences' Property, Plant & Equipment (Net) came in at $11.32 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 23.8% from $14.87 million a year earlier and down 5.6% from the prior quarter.

Analysis

Roivant Sciences (ROIV) Property, Plant & Equipment (Net) (2021 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Roivant Sciences' Property, Plant & Equipment (Net) was $11.99 million, down 0.6% from FY2025.

  • Property, Plant & Equipment (Net) has declined in each of the last three fiscal years, with a five-year compound annual growth rate of -4.1% (FY2021 to FY2026).
  • Going back by fiscal year, Property, Plant & Equipment (Net) was $12.06 million in FY2025 (-21.3%), $15.32 million in FY2024 (-60.8%), $39.09 million in FY2023 (+50.9%) and $25.91 million in FY2022 (+75.6%).
  • The fiscal Q1 2027 figure represents the lowest quarterly Property, Plant & Equipment (Net) in data going back to fiscal Q4 2021.
  • Year-over-year, Property, Plant & Equipment (Net) has declined for three consecutive quarters, with an average decline of 7.2% over the last eight quarters.
  • The fastest year-over-year change in Property, Plant & Equipment (Net) over five years came in fiscal Q2 2023 (growth of 131.7%), and the weakest in fiscal Q4 2024 (a decline of 60.8%).
  • Business Quant data shows ROIV's Property, Plant & Equipment (Net) at $11.99 million (Q4 2026), $13.45 million (Q3 2026) and $25.67 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 29.29 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 23.58 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 5.80 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 25.74 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 10.69 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 13.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 8.55 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 5.83 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 19.03 Bn
10 Roivant Sciences 25.81 Bn 26.50 Bn 1.16 Mn 11.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.32 Mn
Mar 31, 2026 11.99 Mn
Dec 31, 2025 13.45 Mn
Sep 30, 2025 25.67 Mn
Jun 30, 2025 14.87 Mn
Mar 31, 2025 12.06 Mn
Dec 31, 2024 13.56 Mn
Sep 30, 2024 13.67 Mn
Jun 30, 2024 17.84 Mn
Mar 31, 2024 15.32 Mn
Dec 31, 2023 21.86 Mn
Sep 30, 2023 24.48 Mn
Jun 30, 2023 36.27 Mn
Mar 31, 2023 39.09 Mn
Dec 31, 2022 37.30 Mn
Sep 30, 2022 39.17 Mn
Jun 30, 2022 31.69 Mn
Mar 31, 2022 25.91 Mn
Dec 31, 2021 21.61 Mn
Sep 30, 2021 16.90 Mn
API Access

Roivant Sciences Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=ROIV&period=max&api_key=YOUR_API_KEY